| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0001 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.16 | 0.0008 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.002 |